MedPath

Effect of Trigonella foenum, Vaccinium arctostaphylos, Cichorium intybus, Matricaria chamomilla and Urtica dioica extract mixture in treatment of diabetes.

Phase 2
Conditions
Diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20170821035817N3
Lead Sponsor
Iranian academic center for education culture and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Diabetic patients treated with Dietary and hypoglycemic agents
Blood HbA1c level 7.5-8.5 %
Fasting blood glucose levels between 130 to 170 mg/dL
Have diabetes for at least two years
40 to 60 years old

Exclusion Criteria

Patient with renal, hepatic and cardiac failure
Patients with diabetic foot ulcer, gangrene, or any severe illness
Painful diabetic neuropathy and depressed patients
Smokers and alcoholic patients
Patients who tend to change their exercise program or diet

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test.;HbA1C. Timepoint: Baseline and after 3 months at end of the study. Method of measurement: Blood Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath